Carregant...
Harnessing antitumor immunity: Employment of tumor recall antigens to optimize the inflammatory response to cancer
The advent of immunotherapy for cancer has contributed to the era of personalized medicine for cancer. The various immunotherapy-based treatments that have been explored thus far include monoclonal antibody therapy, tumor vaccines, immune checkpoint blockade and adoptive T cell transfer, among other...
Guardat en:
| Publicat a: | Oncol Lett |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5403274/ https://ncbi.nlm.nih.gov/pubmed/28454356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5721 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|